Mode
Text Size
Log in / Sign up

Cross-sectional study links declining nephron number to CKD stage in diabetic nephropathy

Cross-sectional study links declining nephron number to CKD stage in diabetic nephropathy
Photo by asif mohomed / Unsplash
Key Takeaway
Note that single-nephron eGFR decreases with CKD stage in diabetic nephropathy, but clinical utility is unproven.

This is a cross-sectional observational study abstract examining the relationship between CKD stage and renal structural and functional measures in 105 patients with biopsy-proven diabetic nephropathy and overt proteinuria. The authors stratified patients by CKD stage and assessed single-nephron estimated GFR (eGFR), nephron number, glomerular volume, and histologic lesions.

Key findings include a median decline in nephron number from 529,178 to 224,458 per kidney with advancing CKD stage. Single-nephron eGFR decreased markedly with CKD stage and remained significantly inversely associated with CKD stage after adjustment (P for trend <0.001). The percentage of globally sclerotic glomeruli, mesangial expansion score, and prevalence of nodular lesions all increased significantly with advancing CKD stage. Glomerular volume remained constant across stages.

The authors acknowledge limitations: the cross-sectional design cannot establish causality, the single-center study may limit generalizability, and the nephron number estimation method may have measurement error. The study population is limited to patients with overt diabetic nephropathy, so findings may not apply to earlier disease stages.

Practice relevance is restrained: single-nephron eGFR may reveal pathophysiological mechanisms in diabetic nephropathy, but clinical utility remains to be determined. The authors caution against inferring that increasing nephron number would improve outcomes or recommending clinical use of single-nephron eGFR for patient management.

Study Details

Sample sizen = 105
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background: Single-nephron glomerular filtration rate (GFR) represents a nephron-level functional index that may reveal key pathophysiological mechanisms driving progression in patients with diabetic nephropathy. However, its clinical relevance remains incompletely understood. This cross-sectional study assessed single-nephron estimated GFR (eGFR) across different chronic kidney disease (CKD) stages in patients with advanced diabetic nephropathy. Methods: Nephron number was estimated as the number of nonglobally sclerotic glomeruli per kidney using computed tomography-derived cortical volume combined with biopsy stereology. Single-nephron eGFR was calculated by dividing eGFR by the nephron number of both kidneys. Patients were stratified according to CKD stage at kidney biopsy. Associations between CKD stages and single-nephron eGFR were evaluated using multivariable linear regression models adjusted for age, sex, urinary protein excretion, and eGFR. Results: The study included 105 patients with biopsy-proven diabetic nephropathy and overt proteinuria (median age 59 years, 83% male, HbA1c 6.6%, 57% had nephrotic range proteinuria). The percentage of globally sclerotic glomeruli, mesangial expansion score, and prevalence of nodular lesions increased significantly with advancing CKD stage. Median nephron number declined from 529,178 to 224,458 per kidney, whereas glomerular volume remained constant. Single-nephron eGFR decreased markedly with CKD stage and remained significantly inversely associated with CKD stage after adjustment for clinicopathologic covariates (P for trend <0.001). Conclusion: In overt diabetic nephropathy, single-nephron eGFR decreased with advancing CKD stage, despite relatively preserved glomerular volume. At this stage of disease, structural alterations specific to diabetic nephropathy may impair effective single-nephron filtration capacity.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.